Guozhang Xu,Micheal Gaul,Shyh-Ming Yang,Tianbao Lu,Rui Zhang,Fengbin Song
申请号：
US16242902
公开号：
US20190218186A1
申请日:
2019.01.08
申请国别(地区):
US
年份:
2019
代理人:
摘要：
The present invention is directed to indazole derivatives, pharmaceutical compositions containing them and their use in the treatment and/or prevention of disorders and conditions ameliorated by antagonizing one or more glucagon receptors, including for example metabolic diseases such as Type II diabetes mellitus and obesity.
